Effectiveness and safety of tenofovir gel, an antiretroviral microbicide, for the prevention of HIV infection in women.

Abdool Karim, Quarraisha, Abdool Karim, Salim S., Frohlich, Janet A., Grobler, Anneke C., Baxter, Cheryl, Mansoor, Leila E., Kharsany, Ayesha B. M., Sibeko, Sengeziwe, Mlisana, Koleka P., Omar, Zaheen, Gengiah, Tanuja N., Maarschalk, Silvia, Arulappan, Natasha, Mlotshwa, Mukelisiwe, Morris, Lynn, Taylor, Douglas, on behalf of the CAPRISA 004 Trial Group·2010·Science

DOI 10.1126/science.1193748

Cited by (1,005)

Items 401–500 of 1,005

MTN-017: A Rectal Phase 2 Extended Safety and Acceptability Study of Tenofovir Reduced-Glycerin 1% Gel
Cranston, Ross D., Lama, Javier R., Richardson, Barbra A., Carballo-Diéguez, Alex, Kunjara Na Ayudhya, Ratiya Pamela, Liu, Karen, Patterson, Karen B., Leu, Cheng-Shiun, Galaska, Beth, Jacobson, Cindy E. et al. · 2017 · Clinical Infectious Diseases
The promise of pre-exposure prophylaxis with antiretroviral drugs to prevent HIV transmission
Catherine A Hankins, Mark R Dybul · 2012 · Current Opinion in HIV and AIDS
Sustained Release of the CCR5 Inhibitors CMPD167 and Maraviroc from Vaginal Rings in Rhesus Macaques
Karl R. Malcolm, Ronald S. Veazey, Leslie A. Geer, Deborah Lowry, Susan Fetherston, Diarmaid J. Murphy, Peter Boyd, Ian Major, Robin J. Shattock, Per Johan Klasse et al. · 2012 · Antimicrobial Agents and Chemotherapy
Epidemiological Impact of Tenofovir Gel on the HIV Epidemic in South Africa
Brian Gerard Williams, Salim S. Abdool Karim, Quarraisha Abdool Karim, Eleanor Gouws · 2011 · JAIDS Journal of Acquired Immune Deficiency Syndromes
An Intravaginal Ring That Releases the NNRTI MIV-150 Reduces SHIV Transmission in Macaques
Rachel Singer, Paul Mawson, Nina R. Derby, Aixa Rodríguez, Larisa Kizima, Radhika Menon, Daniel Goldman, Jessica Kenney, Meropi Aravantinou, Samantha Seidor et al. · 2012 · Science Translational Medicine
Preventing HIV Infection in Women
Adaora A. Adimora, Catalina B. Ramirez, Judith D. Auerbach, Sevgi O. Aral, Sally Hodder, Gina M. Wingood, Wafaa El‐Sadr, Elizabeth Anne Bukusi · 2013 · JAIDS Journal of Acquired Immune Deficiency Syndromes
Vaginal drug distribution modeling
David F. Katz, Andrew Yuan, Yajing Gao · 2015 · Advanced Drug Delivery Reviews
Vaginal Microbicide Gel for Delivery of IQP-0528, a Pyrimidinedione Analog with a Dual Mechanism of Action against HIV-1
Alamelu Mahalingam, Adam P. Simmons, Shweta R. Ugaonkar, Karen M. Watson, Charlene S. Dezzutti, Lisa Cencia Rohan, Robert W. Buckheit, Patrick F. Kiser · 2011 · Antimicrobial Agents and Chemotherapy
Prevalence of Herpes Simplex Virus Type 2 Infection, Human Immunodeficiency Virus/Herpes Simplex Virus Type 2 Coinfection, and Associated Risk Factors in a National, Population-Based Survey in Kenya
Nelly Mugo, Sufia S. Dadabhai, Rebecca E. Bunnell, John Williamson, Eddas Bennett, Isaack Baya, Nelly Akinyi, Ibrahim Mohamed, Reinhard Kaiser · 2011 · Sexually Transmitted Diseases
Hyperimmune Bovine Colostrum as a Low-Cost, Large-Scale Source of Antibodies with Broad Neutralizing Activity for HIV-1 Envelope with Potential Use in Microbicides
Marit Kramski, Adam K. Wheatley, Jonathan C. Jacobson, Marina R. Alexander, Grant Rawlin, Damian F. J. Purcell · 2012 · Antimicrobial Agents and Chemotherapy
Nanomedicine in the development of anti-HIV microbicides
José das Neves, Rute Nunes, Francisca Rodrigues, Bruno Filipe Carmelino Cardoso Sarmento · 2016 · Advanced Drug Delivery Reviews
Influence of Chitosan Swelling Behaviour on Controlled Release of Tenofovir from Mucoadhesive Vaginal Systems for Prevention of Sexual Transmission of HIV
Fernando Notario-Pérez, Araceli Martín-Illana, Raúl Cazorla-Luna, Roberto Ruíz, Luis Miguel Bedoya, Aitana Tamayo, Juan Rubio, María-Dolores Veiga · 2017 · Marine Drugs
Is expanded HIV treatment preventing new infections? Impact of antiretroviral therapy on sexual risk behaviors in the developing world
Kartik Kailas Venkatesh, Timothy Flanigan, Kenneth Hugh Mayer · 2011 · AIDS
Systemic delivery of tenofovir alafenamide using dissolving and implantable microneedle patches
Alejandro J. Paredes, Fabiana Volpe‐Zanutto, Lalitkumar K. Vora, Ismaiel A. Tekko, Andi Dian Permana, Camila J. Picco, Helen O. McCarthy, Ryan F. Donnelly · 2022 · Materials Today Bio
A natural theaflavins preparation inhibits HIV-1 infection by targeting the entry step: Potential applications for preventing HIV-1 infection
Jie Yang, Lin Li, Suiyi Tan, Hong Wei Jin, Jiayin Qiu, Qin-Chao Mao, Runming Li, Chenglai Xia, Zhi‐Hong Jiang, Shibo Jiang et al. · 2011 · Fitoterapia
Development of sulphated and naphthylsulphonated carbosilane dendrimers as topical microbicides to prevent HIV-1 sexual transmission
Enrique Vacas‐Córdoba, Eduardo Arnáiz, Miguel Relloso, Carlos Sánchez-Torres, Féderico García, Lucía Pérez-Álvarez, Rafael Gómez, F. Javier de la Mata, Marjorie Pion, María Ángeles Muñoz‐Fernández · 2013 · AIDS
Population-based biomedical sexually transmitted infection control interventions for reducing HIV infection
Brian Ng, Lisa Butler, Hacsi Horváth, George Williams Rutherford · 2011 · Cochrane Database of Systematic Reviews
Extended Evaluation of the Virologic, Immunologic, and Clinical Course of Volunteers Who Acquired HIV-1 Infection in a Phase III Vaccine Trial of ALVAC-HIV and AIDSVAX B/E
Supachai Rerks‐Ngarm, Robert Paris, Supamit Chunsutthiwat, Nakorn Premsri, Chawetsan Namwat, Chureeratana Bowonwatanuwong, Shuying S. Li, Jaranit Kaewkungkal, Rapee Trichavaroj, Nampueng Churikanont et al. · 2012 · The Journal of Infectious Diseases
Safety, efficacy, and pharmacokinetics of rilpivirine: systematic review with an emphasis on resource-limited settings
Nathan Paul Ford, Lee, Andrieux-Meyer, Alexandra Calmy · 2011 · HIV/AIDS - Research and Palliative Care
Development of a Transdermal Delivery System for Tenofovir Alafenamide, a Prodrug of Tenofovir with Potent Antiviral Activity Against HIV and HBV
Ashana Puri, Sonalika Arup Bhattaccharjee, Wei Zhang, Meredith R. Clark, Onkar Singh, Gustavo F. Doncel, Ajay K. Banga · 2019 · Pharmaceutics
Mucosal Transmission of Human Immunodeficiency Virus
Denis M. Tebit, Nicaise Ndembi, Aaron Weinberg, Miguel E. Quiñones‐Mateu · 2012 · Current HIV Research
LONG-TERM EPIDEMIOLOGIC TRENDS OF STIs PRE- AND POST-PrEP INTRODUCTION: A NATIONAL TIME-SERIES ANALYSIS
Ferdous Ara Ahmed, Beatrice Onyinyechi Mkpa · 2023
Structure-Based Design and Synthesis of an HIV-1 Entry Inhibitor Exploiting X-ray and Thermodynamic Characterization
Judith M. LaLonde, Matthew Le‐Khac, David M. Jones, Joel R. Courter, Jongwoo Park, Arne Schön, Amy M. Princiotto, Xueling Wu, John R. Mascola, Ernesto Freire et al. · 2013 · ACS Medicinal Chemistry Letters
HIV Treatment Adherence, Patient Health Literacy, and Health Care Provider–Patient Communication
Jean Bisimwa Nachega, Chelsea Morroni, José M Zuniga, Mauro Schechter, Jürgen Kurt Rockstroh, Suniti Solomon, Renslow D. Sherer · 2012 · Journal of the International Association of Physicians in AIDS Care
Interventions to Prevent Sexually Transmitted Infections, Including HIV Infection
Jeanne Marisa Marrazzo, Willard Cates · 2011 · Clinical Infectious Diseases
Composite films for vaginal delivery of tenofovir disoproxil fumarate and emtricitabine
Mafalda P. Cautela, Hen Moshe Halamish, Alejandro Sosnik, Bruno Filipe Carmelino Cardoso Sarmento, José das Neves · 2018 · European Journal of Pharmaceutics and Biopharmaceutics
Rational Development of Liposomal Hydrogels: A Strategy for Topical Vaginal Antiretroviral Drug Delivery in the Context of HIV Prevention
Maria João Faria, Raúl Machado, Artur Ribeiro, Hugo Gonçalves, Maria Elisabete C.D. Real Oliveira, Teresa Viseu, José das Neves, Marlene Lúcio · 2019 · Pharmaceutics
A Phase 1 Randomized, Open Label, Rectal Safety, Acceptability, Pharmacokinetic, and Pharmacodynamic Study of Three Formulations of Tenofovir 1% Gel (the CHARM-01 Study)
Ian McGowan, Ross Cranston, Kathryn Duffill, Aaron Siegel, Jarret C. Engstrom, Alexyi Nikiforov, Cindy E. Jacobson, Khaja K. Rehman, Julie E. Elliott, Elena Khanukhova et al. · 2015 · PLoS ONE
Reducing HIV and AIDS in Adolescents: Opportunities and Challenges
Susan Kasedde, Chewe Luo, Craig McClure, Upjeet Kaur Chandan · 2013 · Current HIV/AIDS Reports
On HIV diversity
Thumbi Ndung’u, Robin A. Weiss · 2012 · AIDS
Inflammation and HIV Transmission in Sub-Saharan Africa
Rupert Kaul, Jessica L. Prodger, Vineet Joag, Brett Shannon, Sergey Yegorov, Ronald Moses Galiwango, Lyle R. McKinnon · 2015 · Current HIV/AIDS Reports
Synergistic activity profile of griffithsin in combination with tenofovir, maraviroc and enfuvirtide against HIV-1 clade C
Geoffrey Férir, Kenneth E. Palmer, Dominique Schols · 2011 · Virology
Conjugation of Cholesterol to HIV-1 Fusion Inhibitor C34 Increases Peptide-Membrane Interactions Potentiating Its Action
Axel Hollmann, Pedro M. Matos, Marcelo T. Augusto, Miguel A. R. B. Castanho, Nuno C. Santos · 2013 · PLoS ONE
Cost–effectiveness of pre-exposure prophylaxis for HIV
Bruce R. Schackman, Ashley A. Eggman · 2012 · Current Opinion in HIV and AIDS
The Surprising Role of Amyloid Fibrils in HIV Infection
Laura M. Castellano, James Shorter · 2012 · Biology
Prevalence of HIV, HSV-2 and pregnancy among high school students in rural KwaZulu-Natal, South Africa: a bio-behavioural cross-sectional survey
Quarraisha Abdool Karim, Ayesha B. M. Kharsany, Kerry Leask, Fanelesibonge Ntombela, Hilton Humphries, Janet Frohlich, Natasha Samsunder, Anneke C Grobler, Rachael C. Dellar, Salim S. Abdool Karim · 2014 · Sexually Transmitted Infections
Animal models in HIV-1 protection and therapy
Ann Jones Hessell, Nancy Logan Haigwood · 2015 · Current Opinion in HIV and AIDS
Antiviral mechanism of polyanionic carbosilane dendrimers against HIV-1
María Ángeles Muñoz‐Fernández, Enrique Vacas‐Córdoba, Marek Maly, F. Javier de la Mata, Rafael Gómez, Marjorie Pion · 2016 · International Journal of Nanomedicine
Clinical implications of the interaction between HPV and HIV infections
Greta Dreyer · 2017 · Best Practice & Research Clinical Obstetrics & Gynaecology
Adherence to pre-exposure prophylaxis among men who have sex with men: A prospective cohort study
Dou Qu, Xiaoni Zhong, Guiyuan Xiao, Jianghong Dai, Hao Liang, Ailong Huang · 2018 · International Journal of Infectious Diseases
Adherence challenges with drugs for pre-exposure prophylaxis to prevent HIV infection
Tanuja Narayansamy Gengiah, Atika Moosa, Anushka Naidoo, Leila Essop Mansoor · 2013 · International Journal of Clinical Pharmacy
A Potent Combination Microbicide that Targets SHIV-RT, HSV-2 and HPV
Larisa Kizima, Aixa Rodríguez, Jessica Kenney, Nina R. Derby, Olga A. Mizenina, Radhika Menon, Samantha Seidor, Shimin Zhang, Keith Levendosky, Ninochka Jean‐Pierre et al. · 2014 · PLoS ONE
A Complex Systems Approach to Evaluate HIV Prevention in Metropolitan Areas: Preliminary Implications for Combination Intervention Strategies
Brandon D. L. Marshall, Magdalena M. Paczkowski, Lars Seemann, Barbara Tempalski, Enrique R. Pouget, Sandro Galea, Samuel R. Friedman · 2012 · PLoS ONE
Vaginal practices as women's agency in Sub-Saharan Africa: A synthesis of meaning and motivation through meta-ethnography
Adriane Martin Hilber, Elise Kenter, Shelagh M. S. Redmond, Sonja Merten, Brigitte Bagnol, Nicola N Low, Ruth Garside · 2012 · Social Science & Medicine
Efficacy of oral pre-exposure prophylaxis (PrEP) for HIV among women with abnormal vaginal microbiota: a post-hoc analysis of the randomised, placebo-controlled Partners PrEP Study
Renee A. Heffron, R. Scott McClelland, Jennifer E. Balkus, Connie Celum, Craig R. Cohen, Nelly Mugo, Elizabeth Anne Bukusi, Deborah J Donnell, Jairam R. Lingappa, James Njogu Kiarie et al. · 2017 · The Lancet HIV
Designing and Developing Suppository Formulations for anti-HIV Drug Delivery
Anthony S. Ham, Robert W. Buckheit · 2017 · Therapeutic Delivery
High Prevalence of Self-Reported Undiagnosed HIV despite High Coverage of HIV Testing: A Cross-Sectional Population Based Sero-Survey in South Africa
Katharina Kranzer, Nienke van Schaik, Unice Karmue, Keren Middelkoop, Elaine Sebastian, Stephen D Lawn, Robin Wood, Linda‐Gail Bekker · 2011 · PLoS ONE
Sex, human rights and AIDS: an analysis of new technologies for HIV prevention in the Brazilian context
Dulce Ferraz, Vera S. Facciolla Paiva · 2015 · Revista Brasileira de Epidemiologia
Social Psychology and the Fight Against AIDS
William A. Fisher, Jeffrey D. Fisher, Paul A. Shuper · 2014 · Advances in experimental social psychology
HIV prevention among female sex workers in Africa
Andrew P. Scheibe, Fatou Drame, Kate Shannon · 2012 · SAHARA-J Journal of Social Aspects of HIV/AIDS
Multipurpose prevention technologies: Products in development
David R. Friend, Justin T. Clark, Patrick F. Kiser, Meredith R. Clark · 2013 · Antiviral Research
Combination HIV Prevention among MSM in South Africa: Results from Agent-based Modeling
Ron Brookmeyer, David Boren, Stefan Baral, Linda‐Gail Bekker, Nancy Refilwe Phaswana-Mafuya, Chris Beyrer, Patrick Sean Sullivan · 2014 · PLoS ONE
Learning from the Messengers: Innate Sensing of Viruses and Cytokine Regulation of Immunity — Clues for Treatments and Vaccines
Jesper Melchjorsen · 2013 · Viruses
Pharmacokinetics and efficacy of a vaginally administered maraviroc gel in rhesus macaques
Karl R. Malcolm, Claire J. Forbes, L. Geer, Ronald S. Veazey, L. Goldman, Per Johan Klasse, J. P. Moore · 2012 · Journal of Antimicrobial Chemotherapy
The Importance of the Vaginal Delivery Route for Antiretrovirals in HIV Prevention
Lindsay M Ferguson, Lisa Cencia Rohan · 2011 · Therapeutic Delivery
Acceptability of Daily Use of Free Oral Pre-exposure Prophylaxis (PrEP) Among Transgender Women Sex Workers in Shenyang, China
Zixin Johnson Wang, Joseph T. F. Lau, Xueying Yang, Yong Cai, Danielle L. Gross, Tiecheng Ma, Yan Liu · 2017 · AIDS and Behavior
A Paclitaxel‐Based Mucoadhesive Nanogel with Multivalent Interactions for Cervical Cancer Therapy
Qiuhui Qian, Leilei Shi, Xihui Gao, Yuan Ma, Jiapei Yang, Zhihao Zhang, Jiwen Qian, Xinyuan Zhu · 2019 · Small
Safety, acceptability, and pharmacokinetics of a monoclonal antibody-based vaginal multipurpose prevention film (MB66): A Phase I randomized trial
Joseph A. Politch, Susan Cu‐Uvin, Thomas R. Moench, Karen T. Tashima, Jai G. Marathe, Kate Morrow Guthrie, Howard Cabral, Tara J. Nyhuis, Miles B. Brennan, Larry Zeitlin et al. · 2021 · PLoS Medicine
Vaginal Mucosa and Drug Delivery
José das Neves, Rita Palmeira‐de‐Oliveira, Ana Palmeira‐de‐Oliveira, Francisca Rodrigues, Bruno Filipe Carmelino Cardoso Sarmento · 2014 · Wiley eBooks
Empowering adolescent girls in Sub‐Saharan Africa to prevent unintended pregnancy and HIV: A critical research gap
Phillips, Sharon J., Mbizvo, Michael T. · 2016 · International Journal of Gynecology & Obstetrics
State of The Science of Adherence in Pre-Exposure Prophylaxis and Microbicide Trials
Felix M. Muchomba, Robin E. Gearing, Jane M. Simoni, Nabila El‐Bassel · 2012 · JAIDS Journal of Acquired Immune Deficiency Syndromes
Preexposure Prophylaxis for HIV Prevention
Theodoros Kelesidis, Raphael J. Landovitz · 2011 · Current HIV/AIDS Reports
Vaginal microbiome modulates topical antiretroviral drug pharmacokinetics
Ekaterina Taneva, Shada Sinclair, Pedro M. M. Mesquita, Brian C. Weinrick, Scott A. Cameron, Natalia Cheshenko, Kerry Reagle, Bruce Frank, Sujatha Srinivasan, David N. Fredricks et al. · 2018 · JCI Insight
Non-aqueous silicone elastomer gels as a vaginal microbicide delivery system for the HIV-1 entry inhibitor maraviroc
Claire J. Forbes, Deborah Lowry, Leslie A. Geer, Ronald S. Veazey, Robin J. Shattock, Per Johan Klasse, Mark A. Mitchnick, Laurie Goldman, Lara A. Doyle, Brendan C.O. Muldoon et al. · 2011 · Journal of Controlled Release
Assessing the Reporting of Adherence and Sexual Activity in a Simulated Microbicide Trial in South Africa: An Interview Mode Experiment Using a Placebo Gel
Barbara Mensch, Paul Hewett, Sharon A. Abbott, Johanna C. Rankin, Sarah Littlefield, Khatija Ahmed, Nazira Cassim, Smruti Patel, Gita Ramjee H, Thesla Palanee‐Phillips et al. · 2010 · AIDS and Behavior
Pharmacokinetics of Antiretrovirals in Genital Secretions and Anatomic Sites of HIV Transmission: Implications for HIV Prevention
Christine Trezza, Angela D. M. Kashuba · 2014 · Clinical Pharmacokinetics
Defining and assessing evidence for the effectiveness of technical assistance in furthering global health
Gary R. West, Sheila P. Clapp, E. Megan Davidson Averill, Willard Cates · 2012 · Global Public Health
Mucus and Mucins: do they have a role in the inhibition of the human immunodeficiency virus?
Anwar Suleman Mall, Habtom H. Habte, Yolanda Mthembu, Julia Peacocke, Corena de Beer · 2017 · Virology Journal
Risk Factors for HIV Acquisition in a Prospective Nairobi-Based Female Sex Worker Cohort
Lyle R. McKinnon, Preston Izulla, Nico J. D. Nagelkerke, Julius Munyao, Tabitha Wanjiru, Souradet Y. Shaw, Richard Gichuki, C Kariuki, Festus K. Muriuki, Helgar Musyoki et al. · 2015 · AIDS and Behavior
Racial/Ethnic Differences in Trust in Health Care: HIV Conspiracy Beliefs and Vaccine Research Participation
Ryan P. Westergaard, Mary Catherine Beach, Somnath S. Saha, Elizabeth A. Jacobs · 2013 · Journal of General Internal Medicine
Assessing Priorities for Combination HIV Prevention Research for Men Who have Sex with Men (MSM) in Africa
Stefan Baral, Andrew P. Scheibe, Patrick Sean Sullivan, Gift Trapence, Andrew Lambert, Linda‐Gail Bekker, Chris Beyrer · 2012 · AIDS and Behavior
Widow cleansing and inheritance among the Luo in Kenya: the need for additional women‐centred HIV prevention options
Brian Perry, Lennah Oluoch, Kawango E. Agot, Jamilah Taylor, Jacob Onyango, Lilian Ouma, Caroline Otieno, Christina Wong, Amy L. Corneli · 2014 · Journal of the International AIDS Society
The lectins griffithsin, cyanovirin-N and scytovirin inhibit HIV-1 binding to the DC-SIGN receptor and transfer to CD4+ cells
Kabamba B. Alexandre, Elin Solomonovna Gray, Hazel Tumelo Mufhandu, James Brislin McMahon, Ereck Chakauya, Barry R. O’Keefe, Rachel Kerina Chikwamba, Lynn Morris · 2011 · Virology
The Beginning of the End of AIDS?
Diane V. Havlir, Chris Beyrer · 2012 · New England Journal of Medicine
Safe and Sustained Vaginal Delivery of Pyrimidinedione HIV-1 Inhibitors from Polyurethane Intravaginal Rings
Todd J. Johnson, Priya Srinivasan, Theodore H. Albright, Karen Watson Buckheit, Lorna K. Rabe, Amy M. Martin, Chou‐Pong Pau, R. Michael Hendry, Ron A. Otten, Janet M. McNicholl et al. · 2011 · Antimicrobial Agents and Chemotherapy
Cultivated Vaginal Microbiomes Alter HIV-1 Infection and Antiretroviral Efficacy in Colonized Epithelial Multilayer Cultures
Richard B. Pyles, Kathleen L. Vincent, Marc M. Baum, Barry L. Elsom, Aaron L. Miller, Carrie Ann Maxwell, Tonyia D Eaves-Pyles, Guangyu Li, Vsevolod L. Popov, Rebecca J. Nusbaum et al. · 2014 · PLoS ONE
Short Communication: Expression of Transporters and Metabolizing Enzymes in the Female Lower Genital Tract: Implications for Microbicide Research
Tian Zhou, Minlu Hu, Marilyn R. Cost, Samuel Mark Poloyac, Lisa Cencia Rohan · 2013 · AIDS Research and Human Retroviruses
The Program Science initiative: improving the planning, implementation and evaluation of HIV/STI prevention programs
Sevgi O. Aral, James Blanchard · 2012 · Sexually Transmitted Infections
Response of Simian Immunodeficiency Virus to the Novel Nucleoside Reverse Transcriptase Inhibitor 4′-Ethynyl-2-Fluoro-2′-Deoxyadenosine In Vitro and In Vivo
Michael Murphey‐Corb, Premeela A. Rajakumar, Heather Michael, Julia Nyaundi, Peter J. Didier, Aaron B. Reeve, Hiroaki Mitsuya, Stefan G. Sarafianos, Michael A. Parniak · 2012 · Antimicrobial Agents and Chemotherapy
Strengthening HIV surveillance in the antiretroviral therapy era: rationale and design of a longitudinal study to monitor HIV prevalence and incidence in the uMgungundlovu District, KwaZulu-Natal, South Africa
Ayesha B. M. Kharsany, Cherie Cawood, David Khanyile, Anneke C Grobler, Lyle R. McKinnon, Natasha Samsunder, Janet Frohlich, Quarraisha Abdool Karim, Adrian J. Puren, Alex Welte et al. · 2015 · BMC Public Health
Potent Inhibition of HIV-1 Replication in Resting CD4 T Cells by Resveratrol and Pterostilbene
Chi Ngai Chan, Benjamin Trinité, David N. Levy · 2017 · Antimicrobial Agents and Chemotherapy
The Human Microbiota, Infectious Disease, and Global Health: Challenges and Opportunities
Abraham J. Waldman, Emily P. Balskus · 2017 · ACS Infectious Diseases
The Acyclic Nucleoside Phosphonates (ANPs): Antonín Holý's Legacy
Erik De Clercq · 2013 · Medicinal Research Reviews
Only a fraction of new HIV infections occur within identifiable stable discordant couples in sub-Saharan Africa
Hiam S. Chemaitelly, James D Shelton, Timothy B. Hallett, Laith Jamal Abu-Raddad · 2012 · AIDS
The need for multipurpose prevention technologies in sub‐Saharan Africa
Salim S. Abdool Karim, Cheryl Baxter, Janet Frohlich, Quarraisha Abdool Karim · 2014 · BJOG An International Journal of Obstetrics & Gynaecology
Comparative Biophysical Properties of Tenofovir-Loaded, Thiolated and Nonthiolated Chitosan Nanoparticles Intended for HIV Prevention
Jianing Meng, Tao Zhang, Vivek Agrahari, Miezan J. M. Ezoulin, Bi-Botti Celestin Youan · 2014 · Nanomedicine
Potential Clinical and Economic Value of Long-Acting Preexposure Prophylaxis for South African Women at High-Risk for HIV Infection
Rochelle P. Walensky, Margo M. Wheatley, Linda‐Gail Bekker, Robert A. Parker, Robin Wood, Stephen Resch, N. Kaye Horstman, Kenneth A. Freedberg, A. David Paltiel · 2015 · The Journal of Infectious Diseases
Divergent adherence estimates with pharmacokinetic and behavioural measures in the MTN‐003 (VOICE) study
Ariane van der Straten, Elizabeth R. Brown, Jeanne Marisa Marrazzo, Michael Chirenje, Karen Liu, Kailazarid Gomez, Mark A. Marzinke, Jeanna M. Piper, Craig W. Hendrix, on behalf of the MTN‐003 VOICE Protocol Team for the Microbicide Trials Network · 2016 · Journal of the International AIDS Society
HIV vaccines: progress to date.
Cynthia Mee Ling Munier, Chris Andersen, Anthony Dominic Kelleher · 2011 · PubMed
Genital—Systemic Chemokine Gradients and the Risk of HIV Acquisition in Women
Lenine J. P. Liebenberg, Lindi Masson, Kelly B. Arnold, Lyle R. McKinnon, Lise Werner, Elizabeth A. Proctor, Derseree Archary, Leila Essop Mansoor, Douglas A. Lauffenburger, Quarraisha Abdool Karim et al. · 2016 · JAIDS Journal of Acquired Immune Deficiency Syndromes
Study designs for identifying risk compensation behavior among users of biomedical HIV prevention technologies: Balancing methodological rigor and research ethics
Kristen Underhill · 2013 · Social Science & Medicine
Reproductive Counseling by Clinic Healthcare Workers in Durban, South Africa: Perspectives from HIV-Infected Men and Women Reporting Serodiscordant Partners
Lynn T. Matthews, Tamaryn L. Crankshaw, Janet Giddy, Angela Kaida, Christina Psaros, Norma C. Ware, Jennifer A. Smit, David R. Bangsberg · 2012 · Infectious Diseases in Obstetrics and Gynecology
Formulation and delivery of anti-HIV rectal microbicides: Advances and challenges
Rute Nunes, Bruno Filipe Carmelino Cardoso Sarmento, José das Neves · 2014 · Journal of Controlled Release
Prevalence and Frequency of Heterosexual Anal Intercourse Among Young People: A Systematic Review and Meta-analysis
Branwen Nia Owen, Patrick M. Brock, Ailsa R. Butler, Michael Pickles, Marc Brisson, Rebecca F. Baggaley, Marie‐Claude Boily · 2015 · AIDS and Behavior
HIV Incidence Remains High in KwaZulu-Natal, South Africa: Evidence from Three Districts
Annalene M. Nel, Zonke Mabude, Jenni A. Smit, Philip L. Kotze, D.D. Arbuckle, Jian Wu, Neliëtte van Niekerk, Janneke H. H. M. van de Wijgert · 2012 · PLoS ONE
PrEP Adherence Patterns Strongly Affect Individual HIV Risk and Observed Efficacy in Randomized Clinical Trials
Dobromir Dimitrov, Benoît R. Mâsse, Deborah J Donnell · 2016 · JAIDS Journal of Acquired Immune Deficiency Syndromes
Combination HIV prevention options for young women in Africa
Cheryl Baxter, Salim S. Abdool Karim · 2016 · African Journal of AIDS Research
The cost-effectiveness of oral HIV pre-exposure prophylaxis and early antiretroviral therapy in the presence of drug resistance among men who have sex with men in San Francisco
Mingwang Shen, Yanni Xiao, Libin Rong, Lauren W. Ancel, Steven E. Bellan · 2018 · BMC Medicine
Antiretroviral Treatment as Prevention
Scott M. Hammer · 2011 · New England Journal of Medicine
A Single Dose of a MIV-150/Zinc Acetate Gel Provides 24 h of Protection Against Vaginal Simian Human Immunodeficiency Virus Reverse Transcriptase Infection, with More Limited Protection Rectally 8–24 h After Gel Use
Jessica Kenney, Rachel Singer, Nina R. Derby, Meropi Aravantinou, Ciby J. Abraham, Radhika Menon, Samantha Seidor, Shimin Zhang, Agegnehu Gettie, James Blanchard et al. · 2012 · AIDS Research and Human Retroviruses